CLINICAL_TRIALS
trial_result
· 2008-02-12
Clinical Trial Update: Safety, Tolerability and Efficacy of ATL-104 in Oral Mucositis [Phase 2]
Summary
Phase 2 trial update evaluating ATL-104 for oral mucositis reports on safety, tolerability, and efficacy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alizyme | Conditions: Mucositis | Phase 2 | Status: COMPLETED